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Abstract
During the Northern Hemisphere winter of 2003–2004 the emergence of a novel influenza antigenic variant, A/Fujian/411/
2002-like(H3N2), was associated with an unusually high number of fatalities in children. Seventeen fatal cases in the UK were
laboratory confirmed for Fujian/411-like viruses. To look for phylogenetic patterns and genetic markers that might be
associated with increased virulence, sequencing and phylogenetic analysis of the whole genomes of 63 viruses isolated
from fatal cases and non fatal ‘‘control’’ cases was undertaken. The analysis revealed the circulation of two main genetic
groups, I and II, both of which contained viruses from fatal cases. No associated amino acid substitutions could be linked
with an exclusive or higher occurrence in fatal cases. The Fujian/411-like viruses in genetic groups I and II completely
displaced other A(H3N2) viruses, but they disappeared after 2004. This study shows that two A(H3N2) virus genotypes
circulated exclusively during the winter of 2003–2004 in the UK and caused an unusually high number of deaths in children.
Host factors related to immune state and differences in genetic background between patients may also play important roles
in determining the outcome of an influenza infection.
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Introduction
Influenza viruses are a common cause of human respiratory
infections [1]. Epidemics occur every year during the winter
seasons in the Northern and Southern Hemispheres and result in
considerable morbidity and mortality. Disease severity is greatest
in the elderly, in infants and in people with certain chronic
diseases. An average of 12,554 deaths occurred in England and
Wales during annual influenza epidemics between 1990–2000 [2].
Acquisition of point mutations in the haemagglutinin glycopro-
tein of influenza A virus leads to continuous antigenic change, a
process called ‘antigenic drift’. This results in continuous
replacement of circulating viruses with new variants which are
able to re-infect hosts despite their immunity to antigenic variants
that circulated previously. In humans, A(H3N2) viruses are
considered to evolve faster than the A(H1N1) subtype [3,4].
Every three to eight years, predominant A(H3N2) viruses are
replaced by a novel antigenic variant, prompting an update of the
recommended influenza vaccine strain [5]. During the 2002–2007
period, the A(H3N2) component of the vaccine was updated four
times [6].
A(H3N2) viruses are associated with increased morbidity and
mortality [7]. The Northern Hemisphere season of 2003–2004
was characterised by the emergence of an antigenic drift variant,
A/Fujian/411/2002, which completely displaced the previously
circulating variant, A/Panama/2007/99. Initial circulation of the
Fujian/411-like variants in the UK and the US was accompanied
by an unusually high number of influenza-associated fatalities in
children [8,9]. Seventeen such laboratory-confirmed influenza
cases were reported in the UK during 2003–2004. Clinical and
pathological findings identified no recognised pre-existing risk
factors for severe influenza illness in 88% of the fatal cases and
only 18% presented secondary bacterial infections. Serological and
community morbidity studies showed increased susceptibility in
the youngest age groups [8]. This posed the question of whether
intrinsic virus virulence or underlying host susceptibility was more
important in determining a fatal outcome. The aim of this study
was to identify any genetic markers of virulence in Fujian/411-like
influenza A viruses from 2003–2004 by sequencing whole
genomes of viruses isolated from fatal and non-fatal paediatric
infections in the UK. Genetic information was used to determine if
virus mutations were associated with fatal outcome by comparison
with genetic features of viruses from previous and subsequent
influenza seasons and viruses from the same season elsewhere.
Results
Whole-genome analysis of influenza sequences from
fatal and non-fatal cases
Sequences of the complete coding regions of influenza whole
genomes were obtained from original respiratory material and/or
viruses isolated from 12/17 fatal cases (Table S2). The remaining
5 fatal cases had HA1 fragment sequences available from original
material only. Three viruses from non-fatal, adult contacts of fatal
case #6 (A/England/740/2003) were also isolated and genome-
sequenced. Further genomes were sequenced from 51 viruses
obtained from non-fatal control cases. Where samples were
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isolate and original material.
Given that the focus of our study was on detecting mutations
that could be associated with more severe infections, we first
sought to establish whether genetic changes could have been
induced during the adaptation to cell culture isolation. Compar-
ison of sequences showed no genetic changes generated through
virus culture for any of the 14 original material/isolate pairs,
except for virus A/England/484/03 (control case) which showed a
mutation G720A in the haemagglutinin (HA) gene sequence from
the viral isolate (corresponding to V242I in the deduced HA
protein). Overlapping peaks were observed at that position in the
HA of the isolate sequence (data not shown), suggesting the
presence of a mixture of variants or quasispecies which may have
been differentially selected through culture.
A phylogenetic tree was inferred using the concatenated
sequences of the main coding regions of 70 viruses (Figure 1
new). For the purpose of comparison, we also included genome
sequences representing the main clusters seen in A(H3N2) viruses
from New York during the season of 2003–2004 [10]. Virus
sequences from the adult contacts of fatal case #6 were not
included in the trees to avoid statistical bias. The analysis revealed
that UK A(H3N2) viruses from 2003–2004 clustered within two
genetic groups, named I and II. Two UK viruses, A/England/
567/2003 and A/Scotland/78/2003 grouped in a single branch,
external to both genetic groups I and II. A third minor genetic
group (III) outgrouping all the others included a single UK strain,
A/England/558/2003 (control case), together with A/Fujian/
411/2002 and two viruses from New York, All viruses isolated
from fatal cases were interspersed with control viruses within
genetic groups I and II, with no evidence for clustering that could
suggest genetic differences specific to the fatal cases viruses.
Next, we constructed phylogenetic trees of the main coding
regions for each gene Figures 2 & 3). The topology of the
individual gene trees was very similar to the concatenated tree,
with distinctive separation of viruses into three genetic groups,
except in the HA phylogeny where the branch corresponding to
genetic group III was not evident.
Evidence for gene reassortment
In general, there was a clear co-segregation of genes from each
virus, as shown by similar phylogenetic topologies, with some
exceptions: a) genes NA, NP and PA from fatal case A/England/
431/2003 (fatal case #4) clustered within genetic group I, whereas
the rest of its genes fell within genetic group II; b) genes from
control case A/England/585/2003 fell into genetic group I,
except for PB2 which fell within genetic group III; c) while most
genes of A/England/558/2003 fell into genetic group III, the HA
fell in a branch whose closest relationship was with genetic group
II; d) genes NP, NA, NS and HA from control viruses A/England/
567/2003 and A/Scotland/78/2003 clearly clustered within
genetic group I, while PB2 and PA fell in a separate distinct
branch that clustered with genetic group I (albeit with ,70%
bootstrap values) - sequences from their PB1 and M genes grouped
in a single branch, external to both genetic groups I and II. These
phylogenetic incongruencies suggest the occurrence of reassort-
ment events for all these viruses. In addition, all the full genome
concatenated sequences were tested for the presence of mosaicism
using bootscanning and informative sites analysis in order to
formally identify recombination breakpoints (Figure S1 & Text
S1). The analysis confirmed the presence of reassortment
(recombination in a concatenated genome) and the breakpoints
detected were consistent with the genes involved in the reassort-
ment for each in the above mentioned viruses.
Amino acid substitutions associated with a fatal outcome
Given the presence of these incongruencies in the phylogenetic
topologies, the number of viruses clustering into each genetic
group varied slightly for each dendrogram. Genetic group II
contained 4–5 out of 12 fatal cases (33–42%), depending on the
gene, but only 8 out of 51 non-fatal cases (16%). The difference
between these percentages was not significant (Fisher’s exact test
values ranging from p=0.107 to p=0.234, depending on the gene
segment).
We next looked at the inferred protein sequences (including
PB1-F2, NS2 & M2) from the gene alignments to determine if
specific amino acid substitutions could be consistently associated
with a fatal outcome. None of the amino acid polymorphisms
present within the whole genome was uniquely or consistently
present in viruses from the fatal cases. Observed signature
substitutions that differentiated genetic groups I and II, as
annotated in Figures 2 & 3, were present in all viruses in these
clusters irrespective of the clinical outcome.
An epidemiological cluster was defined for fatal case #6, A/
England/740/2003: A/England/741/2003 was recovered from a
family contact (sibling of unknown age), while A/England/752/
2003 and A/England/753/2003 were isolated from adult
healthcare workers who had been in contact with the index fatal
case. The contact cases developed influenza-like illness with no
severe complications and fully recovered. Comparison of the
coding regions of the viruses recovered from the A/England/740/
2003 case contacts showed that nucleotide coding sequences were
identical for all genes despite the differences in disease severity
observed.
Glycosylation of haemagglutinin
It has been postulated that, for A(H3N2) viruses, an increase in
the number of potential sites of N-linked glycosylation in the HA
protein resulted in decreased virulence [11]. Ten potential N-
glycosylation sites were identified along the full length HA of both
control and fatal case viruses, at the following residues: 8, 22, 63,
126, 133, 144, 165, 246, 285 (all in HA1) and 483 (in HA2). The
potential glycosylation sites were conserved among the viruses with
the exception of position 126, which was absent in UK viruses
belonging to genetic group I. These findings were related to
phylogenetic clustering and do not associate with a fatal outcome.
Worldwide prevalence of viruses belonging to UK
genetic groups I and II
We next attempted to assess the frequency with which viruses
isolated worldwide during 2003–2004 clustered with UK viruses
belonging to genetic groups I and II. However, when trying to do
so by using whole genome sequences available in GenBank, we
found 413 genomes from A(H3N2) influenza viruses from 2003–
2004, strongly biased towards viruses recovered in the US,
Australia and New Zealand. We therefore performed this
‘prevalence’ phylogenetic analysis with a larger, worldwide-
representative dataset of 1,893 HA1 sequences (positions 346 to
866 of the HA ORF, encompassing the main antigenic sites of the
HA1 glycoprotein) including the UK viruses and all A(H3N2)
viruses isolated in 2003–2004 as available in GenBank [12]. This
allowed us to include those obtained from original material for the
five fatal cases for which full genome sequences were not available.
The phylogenetic relationships in this dendrogram showed that
there was clear evidence of geographical clustering, where most
clusters showed predominance of viruses from the same region or
neighbouring countries (Figure 4). However, in each cluster there
were also sporadic viruses from other regions (not detailed in the
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(highlighted in green) with a robust bootstrap value (80%)
comprising 360 viruses from the rest of Europe (Austria, Finland
and Denmark), North America (US) and Oceania (Australia and
New Zealand). There were at least four subclusters within this
group (condensed for clarity): i) US+UK viruses; ii) UK+Fin-
land+Denmark; iii) Austria; iv) Australia+New Zealand. Genetic
group I UK viruses were also represented in single branches within
this large cluster.
In contrast, genetic group II UK viruses clustered in a small
branch of 29 viruses out of 1,893 with a 100% bootstrap
(highlighted in red). While 15 of these were UK viruses (including
6 from fatal cases) the remaining 14 were from the US (n=5) and
some European countries (France (2), Romania (1), Italy (1),
Sweden (1), Denmark (2) and Norway (2)). The prevalence of
genetic group II viruses worldwide, based on the total number of
HA1 sequences from 2003–2004 available in GenBank, was only
1.5%, compared to a higher prevalence of 22% (n=15/68) in the
UK.
Evolution of A(H3N2) influenza viruses after 2003–2004 in
the UK
To determine the prevalence and/or survival of genetic groups I
and II in subsequent influenza seasons, we analysed our initial set
of viruses in a larger dataset of UK sequences encompassing
influenza seasons from 2002–2003 to 2007–2008, using the same
HA1 fragment selected to construct the phylogeny presented in
Figure 4, again including the sequences from the five ‘HA1 only’
fatal cases.
A total of 159 HA1 sequences were used to build the phylogeny
shown in Figure 5: the two major genetic groups from 2003–2004
are marked as I and II. For each season there was a predominant
replacement of the older viruses by new ones, with some
representatives of each season continuing to survive for one or
two seasons further. There was an almost complete predominance
of viruses falling within the Fujian/411 clade during 2003–2004 in
the UK, all characterized by 12 amino acid substitutions
compared to the UK 2002–2003 (Panama/2007-like) viruses
(Figure 5 & 6). Of these amino acid changes, 10 were located on
the surface of the HA trimer, although two were positioned in the
stalk region; and 9 were located in antigenic sites, Within this
clade, amino acid substitution N126D defines genetic group I and
R142K and S189N, both in antigenic site B, define genetic group
II. However, no viruses belonging to these two genetic groups were
isolated after that season and the major branch spanning all
isolates from 2004–2005 onwards completely diverged from the
genetic group II branch. This suggests that viruses representing
genetic groups I and II did not survive past the 2003–2004 season.
In addition, all viruses characterised since 2004–2005 showed
fixation of at least four amino acid substitutions: K145N, Y159F,
V226I, S227P, relative to the Fujian/411 clade HA1 genetic
groups I and II (Figure 5 & 6). All four changes are exposed on the
surface of the globular head of the HA trimer; positions 145 and
159 lie on antigenic sites A and B, whereas positions 226 and 227
are located on the receptor binding site. A/England/558/2003,
which clustered with post-2003–2004 viruses, exhibited two of
these amino acid changes (Y159F and S227P).
We then compared amino acid substitutions in whole genome
products between Fujian/411-like viruses and earlier (Panama/
2007-like) viruses (Table 1). Given the unavailability of full
genome sequences from UK viruses isolated before 2003–2004, we
used instead a set of 40 viruses from GenBank representative of
seasons 1999–2000 to 2002–2003 for the comparison (listed in
Table S3). Thirteen substitutions were found to distinguish the HA
protein of Fujian/411-like viruses from earlier A(H3N2) viruses.
An additional 26 substitutions differentiated other gene products,
with 11 of them being located in the NA protein. Many of these
mutations (marked with * in Table 1) appeared concomitantly in
the genome of some viruses isolated in Australia and New York in
2001 and 2002. However, this observation did not include changes
seen in the HA sequence.
Discussion
An essential question that remains unanswered is whether virus
virulence or host-related susceptibility factors have the greater
impact on determining the clinical outcome of an influenza
infection. In this study we have analysed a set of viruses obtained
from a series of paediatric fatal cases with laboratory confirmed
A(H3N2) influenza infection, which occurred during the influenza
season of 2003–2004 in the UK. Johnson et al [8] described
clinical and epidemiological findings from these cases and
established some significant facts: (1) 14 of 16 children (88%) for
whom health records were available had no pre-existing risk
factors; (2) none of the children had received the vaccine for winter
2003–2004; (3) three children (18%) had evidence of bacterial co-
infections. This profile indicates a cohort of healthy children who
were likely naı ¨ve to influenza infection in most cases (65% (11)
were under 5 years old) for whom bacterial co-infections may not
have contributed significantly to fatal outcome. Therefore we
sought to determine whether there were patterns in the
phylogenetic relationships or changes in the sequences of the
genes and proteins from virus isolates that could be associated with
a fatal outcome.
In our study we did not find any clear evidence that single
genetic changes in the virus genes or proteins could be associated
with a higher, significant occurrence of severe or fatal cases. The
majority of substitutions observed correspond to signature amino
acid substitutions that differentiated circulating A(H3N2) viruses in
the UK during 2003–2004 into genetic groups I and II; a third
minor genetic group (III) was also observed. These three genetic
groups correlated well with those from 2003–2004 identified in the
US [10], as shown by the inclusion of New York strains in the
phylogeny presented in Figures 1 to 3. The slightly different
topology of genetic group III in the HA phylogeny has been
previously described as a consequence of a reassortment event that
put an HA segment from a 2002–2003 virus into the genomic
background of the Fujian/411-like viruses [10,13]. The existence
of similar phylogenetic patterns in our study and in New York
reinforces the observation that global migration of influenza
viruses is an important component of the seasonal diversity
observed every year [14].
Figure 1. Phylogenetic relationships of the concatenated main coding regions of influenza A(H3N2) viruses isolated in the UK
during 2003–2004. Sequences from reference viruses A/Panama/2007/99 and A/Fujian/411/2002 were included in the dendrograms. For the
purposes of comparison, the dendrograms also included sequences from A/New York/38/2003, A/New York/11/2003, A/New York/32/2003, A/New
York/199/2003 and A/New York/52/2004. All phylogenies were rooted using A/Panama/2007/99 as an outgroup. Branch lengths are drawn to scale.
Viruses isolated from fatal cases are displayed in red type. Bootstrap values (.70%) are displayed on the nodes. Genetic groups I and II are indicated
with brackets. Amino acid substitutions characterising these groups are annotated on the nodes.
doi:10.1371/journal.pone.0033166.g001
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PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e33166Figure 2. Phylogenetic relationships of the main coding regions of PB2, PB1, PA & HA of influenza A(H3N2) viruses isolated in the
UK during 2003–2004. Details are similar to those described in Figure 1 footnote.
doi:10.1371/journal.pone.0033166.g002
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PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e33166Figure 3. Phylogenetic relationships of the main coding regions of NP, NA, M & NS of influenza A(H3N2) viruses isolated in the UK
during 2003–2004. Details are similar to those described in Figure 1 footnote.
doi:10.1371/journal.pone.0033166.g003
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primary clinical samples revealed that only one pair differed by a
nonsilent mutation in the HA. Host-mediated mutations are a
well-known consequence of adaptation to laboratory culture and
are a potential source of problems in evolutionary studies [15].
However, finding only one mutated nucleotide out of 183148
(13082 bases per whole genome) would indicate that the effect of
cell-culture mediated mutations is irrelevant in our study.
Overlapping peaks in the mutated sequence suggested the
presence of a mixture of variants in that isolate. The use of deep
sequencing would have added valuable information on the
diversity of the virus population within each sample. However,
as most viruses had only isolates available for sequencing, any
attempt to apply deep sequencing to the analysis of intrasample
diversity would have been invalidated by the potential selection of
variants in tissue culture, therefore not reflecting the true
proportion of quasiespecies, if present, in the primary clinical
material.
Although the majority of individual gene segments showed
identical clustering in phylogenies, there were at least four
topological change events in the dendrograms, strongly suggesting
evidence of reassortment (Figures 2 & 3), also confirmed by
bootscanning and informative sites analysis. This adds further
support to the notion that gene reassortment among same-subtype
strains is a major driving force for evolution in influenza A virus
[16]. When analyzing the worldwide occurrence of variants
circulating during 2003–2004 we observed a low frequency of
genetic group II viruses (1.5%, Figure 4), compared with a higher
frequency in the UK, both for fatal (33 or 42%) and non-fatal
(16%) cases, which suggest overrepresentation of genetic group II
viruses in the UK in 2003–2004. Although we included the total
number of HA1 sequences for influenza A(H3N2) viruses from
2003–2004 available in GenBank for this analysis, we acknowledge
the limitations of using GenBank numbers to make epidemiolog-
ical assumptions, as numbers of sequences are not representative
of the population; also, some countries are overrepresented while
some do not submit sequence data, so it is possible that genetic
group II viruses could have circulated in high frequencies in other
geographic locations with poor surveillance system.
Fujian/411-like viruses completely replaced the Panama/2007-
like variants circulating in 2002–2003, as shown by analysis of
genetic groups I and II in a set of 159 partial HA1 sequences
spanning six consecutive influenza seasons from 2002–2003.
However, while Fujian/411-like antigenic variants predominated
during the 2003–2004 season in the UK, they did not circulate
thereafter [17]. In our study, at least 12 amino acid substitutions in
the HA1 glycoprotein mark the transition between Panama/2007-
and Fujian/411-like viruses. The majority were located on the
surface of the HA trimer and within one of the five antigenic sites
proposed for H3 haemagglutinin [18,19], therefore showing
potential for antigenic variation, although only H155T and
Q156H were actually responsible for the antigenic drift [20].
Four further amino acid substitutions in HA1 differentiate the
Fujian/411-like viruses from viruses isolated after 2003–2004. All
of them were also exposed on the surface of the globular head,
either related to antigenic sites A or B, or located in the receptor
binding site. In our study, the Fujian/411-like viruses exhibited
substitutions W222R and G225D when compared to the previous
Panama/2007-like variants. Recently, substitution D225G in the
HA (D222G by H1 numbering) of pandemic influenza A(H1N1)
2009 viruses has been implicated in higher severity and fatal cases
[21]. This substitution has been shown to induce alterations in the
receptor binding site, increasing the affinity of these viruses for
receptors expressed on ciliated bronchial epithelial cells and on
epithelia within the lung [22]. Position 226 (H3 numbering) has
also been implicated in changes of receptor binding specificity, cell
tropism and host range restriction for several human and animal
influenza subtypes [23,24,25,26]. In summary, HA changes
distinguishing the transition between Panama/2007-like, Fujian/
411-like and later viruses have enough potential for altering
biological properties such as antigenicity, receptor binding affinity
or others which in turn might affect virus virulence.
An additional 26 substitutions were shown to distinguish the
remaining gene products of Fujian/411-like viruses from earlier
(Panama/2007-like) viruses. Eighteen of them were already
detected concurrently in viruses isolated in 2001 and 2002,
suggesting that the genomic background of the Fujian/411-like
viruses was already circulating at that time. However, these viruses
did not have the HA changes seen in the Fujian/411-like viruses,
an observation that corresponds with other reports suggesting that
the HA gene of Fujian/411-like viruses was only placed by
reassortment into the genomic background of the Fujian/411-like
viruses shortly before the 2003–2004 season [10,13]. It has also
been suggested that interaction among viral proteins may play a
key role in the fitness and virulence of a virus [10]. Some of the
genomic substitutions observed in the Fujian/411-like viruses were
related to host range specificity. For instance, substitution I667V
in PB2 represents a human-to-avian specific change [27].
Substitutions V421I(PB1) and T9N(PB2) were described as
human-like changes in H5N1 viruses with increased pathogenicity
in mice [28]. The biological relevance of substitutions I421V and
N9T (characteristic of genetic group I) seen in the Fujian/411-like
viruses is unknown. Substitutions at positions 27, 103, 146 and 197
in NP are located in known virus cytotoxic T lymphocyte (CTL)
epitopes [29,30,31] and they may confer on Fujian/411-like
viruses a higher efficiency of escape from CTL-mediated immune
responses. Substitutions at positions 172, 199 and 370 in NA are
located in antigenic sites [32], while the K93N substitution
introduces an additional potential glycosylation site; all/some of
these may contribute to the antigenic drift seen in Fujian/411-like
viruses. Many of these substitutions (marked with * in Table 1)
have been seen concomitantly in the genome of some A(H3N2)
viruses from before 2003–2004. A search in the NCBI Influenza
Virus Resource through all the available A(H3N2) genome
sequences (.2,000) showed that viruses exhibiting these substitu-
tions were seen from seasons 2001–2002 to 2003–2004 disap-
pearing thereafter, consistent with the replacement of the Fujian/
411-like viruses in 2004–2005 in a genome-wide sweep, as
previously described [3].
While Fujian/411-like viruses exhibited a unique gene constel-
lation and carried HA amino acid substitutions that caused
significant antigenic drift [33] and replacement of all other
Figure 4. Phylogenetic relationships of partial sequences (nucleotides 346 to 866) of the HA1 coding fragment for A(H3N2) viruses
isolated in 2003–2004 in the UK and worldwide. Genetic groups where viruses from the UK clustered are highlighted in green (I) and red (II).
Some branches were condensed for clarity purposes; adjacent legends indicate the country/region where the majority of viruses within a cluster were
isolated and the number of viruses included. These clusters also included sporadic viruses from other countries which were not detailed. Sequences
from reference viruses A/Panama/2007/99 and A/Fujian/411/2002 were included in the phylogeny. The ML phylogeny was rooted using A/Panama/
2007/99 as an outgroup. Branch lengths are drawn to scale. Bootstrap values (.70%) are displayed on the nodes.
doi:10.1371/journal.pone.0033166.g004
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changes and consequent amino acid substitutions could be related
to severe or fatal clinical outcomes. On this basis, we conclude that
host-related susceptibility was the major determinant of severe
illness or death due to infection by Fujian/411-like viruses in
2003–2004. It is likely that, if any virus feature contributed to a
more severe outcome, this occurred in the context of naı ¨ve
children undergoing what was likely to be their first influenza
infection.
Clinical incidences of influenza-like illness (ILI) in young age
groups were shown to be at their highest in the years when novel
antigenic drift variants emerged [8]. Similarly, studies of mortality
in children associated with pandemic influenza A(H1N1) 2009
revealed the highest mortality rate in children aged less than 1 year
and a substantial proportion of children with no pre-existing
disorders (27%) who rapidly deteriorated and died [34,35]. Seven
out of 17 paediatric deaths in the UK in 2003–2004 occurred
suddenly with no previous illness or within a day of the onset of
symptoms, with no obvious link to a predominance of genetic
groups I or II viruses among these cases. Overall, we found no
consistent relationship between the genetic features of these viruses
and the main clinical findings observed for the UK paediatric fatal
cases (Table S2).
The contribution of host factors to the outcome of an influenza
infection is supported by our finding that the same, genetically
identical virus (represented by A/England/740/2003) could cause
death in a child while causing uncomplicated respiratory illness in
one family contact (a sibling of unknown age) and two non-related
adult contacts. Factors related to the infecting-dose of virus could
not be determined. Innate immune response, preexisting adaptive
immunity, genetic background [36,37] and even environmental
conditions surrounding host and virus (reviewed in [38]) are all
factors that can contribute to virus pathogenesis.
Limitations of the present study include the probable underes-
timate of the number of paediatric death cases during the 2003–
2004 influenza season as we have studied only those reported to
the HPA and laboratory-confirmed. Since this time, reporting
mechanism of fatal cases has been strengthened. Also, the whole
genome sequence data available outside the UK was biased to
specific countries and this may have altered the interpretation.
However, this study reinforces the conclusion that the virulence of
an influenza virus results from a complex interplay between
polygenic virus virulence factors, the host immune response and
host genetic factors. Any difference in virulence between genetic
groups I and II viruses could be tested in animal models by using
recombinant viruses generated through reverse genetic systems. It
Figure 5. Phylogenetic relationships of partial sequences (nucleotides 346 to 866) of the HA1 coding fragment for A(H3N2) viruses
isolated between 2002 and 2008 in the UK. The annotated box indicates the reference colours for viruses isolated in different influenza seasons,
between 2002–2003 and 2007–2008. Genetic groups I and II, within the Fujian/411 clade, are indicated with brackets. Viruses from fatal cases are
highlighted with #. Sequences from reference viruses A/Panama/2007/99 and A/Fujian/411/2002 were included in the phylogeny. The ML tree was
rooted using A/Panama/2007/99 as an outgroup. Branch lengths are drawn to scale. Bootstrap values (.50%) and signature amino acid substitutions
seen in viruses from 2003–2004 and 2004–05 are annotated on the nodes.
doi:10.1371/journal.pone.0033166.g005
Figure 6. Surface representation of the hemagglutinin hetero-trimer from a seasonal H3N2 strain [47]. Location of the amino acids
substitutions marking the transition between Panama-like and Fujian-like viruses are highlighted in red; those changes which differentiate viruses
isolated since 2004–2005 from Fujian/411-like viruses are coloured in blue; genetic group I-specific changes are highlighted in green and genetic
group II-specific changes are marked with yellow.
doi:10.1371/journal.pone.0033166.g006
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were all more virulent than previously circulating viruses.
Alternatively, if any virus factor was contributing to a higher
virulence, its relative impact could have been substantial in the
context of a highly susceptible host. Additional studies are needed
to better identify host genetic determinants of severe influenza
infection, perhaps focussing on human genes responsible for the
development of an atypical antiviral innate immune response. This
could be a critical factor that leads to severe illness and death in
naı ¨ve hosts. The matching of virus genomics with clinical and
epidemiological findings is an important tool for studying highly
mutable pathogens, such as influenza A virus. The methodology
carried out in this study will be useful in the analysis of seasonal
epidemics of influenza and also in the study of the recently
emerged pandemic influenza A(H1N1) 2009 virus.
Materials and Methods
Ethics statement
This study was conducted as part of a public health inquiry by
the Health Protection Agency and Health Protection Scotland into
paediatric deaths, where it was agreed that ethical approval for
linking personal clinical outcome information to virus character-
isation was not required.
Fatal and control cases
Seventeen fatal cases of laboratory-confirmed influenza A in
children under eighteen years were reported to HPA between
September and December 2003. The median age was two years
(range 4 months – 17 years); eleven (64%) were under five years of
age and ten (58%) were females. Further clinical findings are
described in Johnson et al [8]. Three control cases were selected
per fatal case, on the basis of matching age, week of infection and
geographical location. HPA influenza surveillance relies on the
timely collection of clinical and virological data across the UK.
Information sources have been described previously [33]. Overall,
over 80% of reported laboratory-confirmed cases have respiratory
specimens referred to National Reference Laboratory.
Viruses
Respiratory samples and tissue biopsy samples were received at
HPA for laboratory confirmation of A(H3N2) influenza virus
infection and further characterisation of the infecting viruses.
Original material was inoculated onto either Madin-Darby canine
kidney cells (MDCK) or the SIAT1 derivative [39]. Virological
data is described with more details elsewhere [33].
Whole genome sequencing
Virus RNA was extracted from either aliquots of original
respiratory/biopsy material or from virus isolates using a Qiagen
viral RNA mini kit (Qiagen Ltd, Crawley, West Sussex, England).
Complete genomes were amplified using a one-step RT-PCR
procedure employing Superscript III RT and Platinum Pfx,a
proof-reading DNA polymerase (Invitrogen Ltd, Paisley, England).
RT-PCR products were purified using QIAquick gel extraction
and PCR purification kit (Qiagen). Sequences were obtained by a
gene-walking approach using a commercial sequencing service
(GATC Biotech Ltd, Cambridge, England). Specific primers for
amplification and sequencing are described in Table S1. Genbank
accession numbers range from CY087969 to CY088568 for virus
isolate sequences and from CY107071 to CY107182 for original
material sequences.
Phylogenetic analyses
Raw sequencing data was edited and assembled into continuous
gene sequences (contigs) covering the entire ORF of each gene
using Sequencher 4.9 (http://www.genecodes.com).
Nucleotide sequences for each gene segment were aligned using
ClustalX 1.81 [40]. Alignments were edited with BioEdit 7.0.5.3
[41]. Maximum Likelihood (ML) phylogenetic trees of each gene
segment were inferred using the PAUP 4.0 package (Swofford DL;
Sinauer Associates). The best-fit model of nucleotide substitution
was identified using Modeltest [42] as the general-time reversible
GTR+C4 model for most genes, except for NP (GTR+I), NS
(GTR) and M (HKY85+C4). Nucleotide frequencies, transition-
transversion ratio, proportion of invariable sites and gamma
distribution of among-site rate variation were estimated from the
Table 1. Amino acid substitutions in the inferred protein sequences that distinguish UK Fujian/411-like viruses from earlier
(Panama/2007-like) viruses.
PB2 PB1 PB1-F2 PA HA NP NA M1 M2 NS1 NS2
R389K* T469I* none D27N* L25I A27S* K93N none none E71G* K88R*
I667V* K262R* R50G R98K* R143G
S332T* H75Q K103R* K172R*
I348V* E83K T146A* H197D
I421V* A131T V197I* E199K
H155T D208N
Q156H R249K
S186G T265I*
V202I K267T
W222R S370L
G225D Q432E*
E386G
V530A
Amino acid substitutions are described using the protein sequences of the A/Panama/2007/99 vaccine virus as reference.
*Indicates changes appearing concomitantly in viruses from different countries in 1999–2002 (see Table S3).
doi:10.1371/journal.pone.0033166.t001
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heuristic search using the tree bisection-reconnection branch-
swapping algorithm.
Bootstrap analysis was performed through the Neighbor Joining
algorithm with 1,000 replicates, incorporating the ML substitution
model previously determined for each gene with Modeltest.
Two large datasets, the set of 1,893 sequences used to generate
the phylogeny presented in Figure 4 and the 70 sequences formed
by alphabetic concatenation of influenza coding regions (Figure 1)
were aligned using a parallel implementation of ClustalW,
ClustalW-MPI [43]. Phylogenetic trees from these alignments
were inferred using a rapid parallelised ML inference method;
RAxML [44]. RAxML utilises the general-time reversible (GTR)
model of nucleotide substitution and performs heuristic ML
searches using maximum parsimony trees as starting points. The
trees were created using 200 independent inferences and 1,000
bootstrap replicates.
Identification of recombination/reassortment breakpoints in the
concatenated whole genome sequences through bootscanning and
informative site analysis was performed using Simplot v3.2 [45]
Potential N-glycosylation sites in the deduced amino acid
sequences were predicted using NetNGlyc version 1.0 [46].
Structural analysis
A model of the HA influenza trimer was generated using an X-
ray crystallographic structure (PDB code: 2VIU [47]) downloaded
from the Protein Data Bank website [48]. The structure was
manipulated and presented using PyMOL. One monomer of HA
trimer was highlighted to indicate the arrangement of monomers
within the overall trimers. The structural position of amino acid
variants discriminating between Panama/Fujian/later strains and
the positions specific to genetic groups I and II were highlighted
and labelled on the trimeric structure.
Supporting Information
Figure S1 Bootscan analysis for reassortant UK viruses.
A) A/England/431/2003; B) A/England/585/2003; C) A/
England/558/2003; D) A/England/567/2003; E) A/Scotland/
78/2003.
(TIF)
Table S1 Primers for whole genome sequencing of
Influenza A(H3N2) viruses. Primers for gene fragment
amplification and sequencing are highlighted in bold.
(DOC)
Table S2 Relationship between phylogenetic clustering
of viruses from fatal cases and main clinical findings
(described with more detail in [8]).
(DOC)
Table S3 Set of A(H3N2) viruses selected from GenBank
and used for the amino acid substitution comparison
featured in Table 1.
(DOC)
Text S1 FindSites analysis of the reassortant UK
viruses.
(RTF)
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